San Diego, CA, November 19, 2004 The Washington Neuropsychological Institute today announced that preliminary data suggested that ADDERALL XR significantly improved simulated driving performance in young adults aged 19 to 25 years with attention-deficit/hyperactivity disorder (ADHD) for up to 12 hours after taking the medication, as compared with placebo. In addition, ADDERALL XR significantly improved ADHD symptom control of young adults with ADHD as compared with placebo. This preliminary, six-week, double-blind, placebo-controlled crossover study, led by Gary G. Kay, Ph.D., Washington Neuropsychological Institute, Washington, DC, was presented today at the 17th Annual U.S. Psychiatric & Mental Health Congress in San Diego, CA.
"The symptoms of ADHD can significantly affect a person's ability to focus and respond to changing conditions while driving, which can obviously have very serious consequences," said Dr. Gary Kay, Ph.D., president of the Washington Neuropsychological Institute. "Young adults with ADHD receive twice the number of traffic violations and have more license suspensions and revocations than their peers without ADHD. Records also show that people with ADHD were at fault in more car crashes and were involved in more severe car accidents than people without ADHD. This study provides us with important data demonstrating that ADDERALL XR can help young adults control their ADHD symptoms throughout a 12-hour day and therefore improve their ability to drive better and more safely."
The three main symptoms of ADHD include inattention, hyperactivity and impulsivity. Up to 65 percent of children with ADHD may still exhibit symptoms into adulthood. If left untreated, these symptoms may seriously and adversely affect patients as well as their families and friends. Over 8 million adults in the U.S. may exhibit symptoms of ADHD. Appropriate diagnosis and treatment of ADHD in adults helps improve self-esteem, work performance and
'"/>
Contact: Dr. Gary Kay, Washington Neuropsychological Institute
202-256-5617
Porter Novelli
18-Nov-2004
Page: 1 2 3 4 Related medicine news :1.
Fat may promote inflammation, new study suggests2.
New studies suggest airborne SARS transmission is possible3.
Doctor suggested cannabis for pain relief, says one in six medicinal users in the UKMUHC study4.
Research suggests possible blood test for multiple sclerosis5.
Short-term effects of spit tobacco suggest long-term health risks6.
Study suggests smoking while pregnant may increase chromosomal abnormalities in fetal cells7.
Chemicals in apples could reduce the risk of breast cancer, Cornell study in rats suggests8.
Major review of subway systems suggests potential for significant health and safety hazards9.
Herb used to treat diabetes works like modern-day prescription drugs, study suggests10.
Abandoned bones suggest TB wiped out leprosy in battle of killer diseases11.
Effects of autism reach beyond language, new research suggests